Updated:
Tiger Jade Capital
Tiger Jade Capital is a Hong Kong-based private equity firm investing from seed to pre-IPO across Asia.
Tiger Jade Capital
Tiger Jade Capital is a Private Equity fund focused on global healthcare industry. It is a comprehensive healthcare fund covering new drugs, CRO, medical equipment, etc.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
Hong Kong
City
Hong Kong
Corporate office
Hong Kong, Hong Kong
Frequently asked questions
What investment stages does Tiger Jade Capital target?
Tiger Jade Capital deploys capital from seed and start-up stage through to pre-IPO rounds, according to the firm's disclosed strategy. This full-lifecycle approach means the firm can enter at a company's earliest funding rounds and maintain its position through later growth-stage financings. The structure avoids the typical hand-off between early-stage and growth-stage investors.
Who runs investment decisions at Tiger Jade Capital?
Tiger Jade Capital has not publicly named its founding partners or investment committee members. The firm operates from Hong Kong and its website does not list a team page or principal biographies. Allocators conducting due diligence will need to request this information directly from the firm.
Does Tiger Jade Capital invest only in Asia-based companies?
Tiger Jade is headquartered in Hong Kong and positions itself as an Asia-focused private equity firm. The firm has not published a geographic mandate document, but its Hong Kong base and regional framing suggest portfolio companies are predominantly Asia-headquartered or generate the bulk of their revenue within Asia.
Is Tiger Jade Capital structured as a venture capital firm or a private equity firm?
Tiger Jade describes itself as a private equity firm, but its strategy spans early-stage venture and pre-IPO growth equity. This is more accurately a full-lifecycle private investment model than a pure venture capital or buyout approach. The firm's mandate allows it to hold positions from a company's first institutional round through to public listing.
What is Tiger Jade Capital's known posture on co-investments alongside external GPs?
Tiger Jade Capital has not publicly stated its co-investment policy. The firm's direct investment mandate suggests it leads or participates in primary rounds rather than investing as a limited partner in third-party funds. Allocators should confirm co-investment appetite and minimum commitment sizes in direct discussions.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: